Abstract: The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Y and W are as defined herein. The invention also concerns a method for preparing said compounds and their therapeutic use.

Abstract: The present invention relates to aryl oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.

Abstract: The present application relates to thiazolylidene containing compounds of formula (I) wherein R1, R2, R3, and R4 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

Abstract: Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compounds of Formula I, B or R2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH2—.

Abstract: The present disclosure relates to lipid compounds of the general formula (I): R1-O—C(R2)(R3)-X??(I) wherein R1 is a C10-C22 alkyl group, a C10-C22 alkenyl group having 1-6 double bonds, or a C10-C22 alkynyl group having 1-6 triple bonds; R2 and R3 are the same or different and may be chosen from different substituents; and X is a carboxylic acid or a derivative thereof, such as a carboxylic ester, a carboxylic anhydride, a phospholipid, triglyceride, or a carboxamide; or a pharmaceutically acceptable salt, solvate, solvate of such salt or a prodrug thereof. The present disclosure also relates to pharmaceutical compositions and lipid compositions comprising at least one compound according to the present disclosure, and to such compounds for use as medicaments or for use in therapy, in particular for the treatment of diseases related to the cardiovascular, metabolic, and inflammatory disease area.

Abstract: The present invention relates to imidazolidinecarboxamide derivatives of the general formula I, wherein R, R1, R2, X and Y are as defined herein, or pharmaceutically usable salts thereof and the use thereof as medicinal substances.

Abstract: A compound having selective modulating activity at the alpha 2B and/or alpha 2C adrenergic receptor subtypes is represented by the general Formula 1: wherein n=1-4; X is C or N; R1-R6 can be the same or different and are independently selected from the group consisting of H, C1-6 alkyl, OCH3, OH, F, Cl, Br, CH2OH, CH2N(R7)2, C(O)R8, CH2CN, CF3, wherein R7 is H or C1-6 alkyl; and R8 is C1-6 alkyl or aryl. The compounds of Formula 1 can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.

Abstract: The present invention relates to a novel chlorin e6-folic acid conjugate, a preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same, and more particularly, to a novel compound prepared by linking chlorin e6 to folic acid, which effectively produces singlet oxygen in various media and has much better tumor selectivity than the known porphyrin-based photosensitizers, thereby being used effectively in photodynamic therapy for malignant tumors, a preparation method thereof, and a pharmaceutical composition for photodynamic treatment of solid tumors comprising the compound as an active ingredient.

Abstract: This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.

Abstract: One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.

Abstract: Disclosed are: a composition for alleviating ultraviolet irradiation-induced damage, which can be used on a daily based and is stable and safe; and a pharmaceutical preparation, a cosmetic and a food composition, each of which comprises the composition. The composition for alleviating ultraviolet irradiation-induced damage contains one or more compounds selected from the group consisting of D-glutamic acid, L-glutamic acid, D-proline, D-cystine, L-cystine, and derivatives and/or salts of the aforementioned compounds. The composition can be used as an external formulation for the skin, a cosmetic composition, an anti-wrinkle agent, a sunscreen agent, a pharmaceutical composition for treating and/or preventing skin diseases, a food composition, or a pharmaceutical composition for preventing or treating cataract.

Abstract: The method of treating diabetes-related vascular complications includes the treatment of diabetic patients with ?-lipoic acid (LA) in order to mitigate the negative impact of diabetes-related vascular dysfunctions upon vascular homeostasis. The treatment method includes the step of administering to the patient an initial dosage of ?-lipoic acid believed to be therapeutically effective. The patient's response is then monitored by measuring ?-lipoic acid-responsive biomarkers and by performing assays from blood and tissue taken from the patient.

Abstract: The present invention relates to novel fluorinated 3,6-diaminoxanthene compounds derived from the basic structural formula (I) and to their uses as photostable fluorescent dyes, e.g. for immunostainings and spectroscopic and microscopic applications, in particular in conventional microscopy, stimulated emission depletion (STED) reversible saturable optically linear fluorescent transitions (RESOLFT) microscopy, and fluorescence correlation spectroscopy. The claimed compounds are also useful as molecular probes in various spectroscopic applications.

Abstract: Inhibitors of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), for example tetrazole, styrylpyrazole, phenylfuran, phenylthiophene, phenylpyrrazole, pyrazolecarboxamide, 2-thioacetamide and azo compounds, are useful for promoting or stimulating pigmentation of the skin and/or skin appendages and/or for preventing and/or for limiting depigmentation and/or whitening of the skin and/or skin appendages, notably for preventing and/or limiting canities.

Abstract: The invention relates to a sensory stimulant composition containing one or more of vanillin acetals represented by the general formula (1), and a flavor and fragrance composition, a beverage or food product, a fragrance or cosmetic product, a daily utensil product, an oral composition, or a pharmaceutical product containing the sensory stimulant composition with a warming sensation agent or cooling sensation substance, if necessary. Vanillin acetals represented by the general formula (1) show an excellent pungent and/or warming sensation effect and a cooling sensation-emphasizing effect.

Abstract: The disclosure is in part directed to crystalline forms of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol and variants thereof.

Abstract: Nitro oleic acid and related metabolites are agonists of PPAR-?. Surprisingly, nitro oleic acid is a more potent agonist of PPAR-?, relative to nitro linoleic acid. Thus, nitro oleic acid and its metabolites, as well as their pharmaceutically acceptable salts and prodrug forms, are candidate therapeutics for the treatment of type-2 diabetes, which results from insulin resistance accompanying the improper functioning of PPAR-?.

Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.

Abstract: The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.

Abstract: Methods of treating a patient in need thereof, comprising administering to the critically ill patient an intravenous pharmaceutical composition comprising ibuprofen in an amount effective to treat at least one condition in the patient chosen from pain, inflammation, and fever and to provide a clinically relevant effect on mean arterial pressure of the patients during the dosage interval comprising no increase or no statistically significant increase in mean arterial pressure.

Abstract: The present invention is related to uses of a composition comprising a pharmaceutically active component and a compound according to formula (I), wherein R1 and R2 are each and independently selected from the group comprising alkyl; n is any integer between 1 and 4; R3 is an acyl selected from the group comprising lysyl, ornithyl, 2,4-diaminobutyryl, histidyl and an acyl moiety according to formula (II), wherein m is any integer from 1 to 3 and Y? is a pharmaceutically acceptable anion.

Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Abstract: Articles that contain a solid support with a grafted chain extending from the solid support, methods of making these articles, and various uses of the articles are described. More specifically, the grafted chain has a functional group that can react with or interact with target compound. Alternatively, the functional group on the grafted chain can react with a modifying agent to provide another group that can react with or interact with the target compound. The grafted chains are attached to the solid support through a ring-opened azlactone group. The articles can be used to purify the target compound or to separate the target compound from other molecules in a sample.

Abstract: A process for producing a thermoplastic resin composition includes kneading a mixture obtained by combining a rubber component with a ground product, the ground product being formed by grinding a thermoplastic resin molded article having an alloy resin of a polycarbonate and an ABS, and then molding the mixture after kneading. The mixture has 0.5 wt % or more and 1.5 wt % or less of the rubber component based on 100 wt % of the mixture.

Abstract: In one aspect, the invention relates to recycled polyethylene terephthalate compositions, fibers and articles produced therefrom, and methods for producing same. In a further aspect, the invention relates to homogenized post-consumer polyethylene terephthalate. In a further aspect, the invention relates to extruded polymer compositions, polymer mixtures, fibers, and/or Bulked Continuous Filament fibers comprising post-consumer polyethylene terephthalate. In a further aspect, the invention relates to processes for preparing recycled polyethylene terephthalate compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: Aqueous cold-cure flexible foam stabilizer including the following components: a) from ?0.1 to ?80% by weight of at least one water-insoluble polysiloxane compound having a molecular weight of from ?300 g/mol to ?10 000 g/mol, b) ?2% by weight of water, c) ?0.1% by weight of surfactant, d) from ?0 to 10% by weight of additives selected from the group consisting of thickeners, antifreezes, organic solvents and biocides, e) ?0% by weight of water-soluble siloxane(s), with the proportion by weight of the abovementioned components being selected so that the sum of the proportions by weight of the components is not more than 100% by weight, based on the aqueous cold-cure flexible foam stabilizer formulation.

Abstract: Provided are a composition for preparing expandable polypropylene carbonate and an expandable polypropylene carbonate prepared therefrom, and more particularly, to a composition for preparing expandable polypropylene carbonate capable of using supercritical carbon dioxide as a foaming agent and producing a foam having excellent moldability by using an appropriate foaming method. By using the composition according to the present invention, highly magnificated expandable polypropylene carbonate capable of having excellent thermal stability and dimensional stability can be prepared.

Abstract: The invention relates to a foamed isocyanate-based polymer derived from a reaction mixture comprising an isocyanate, an active hydrogen-containing compound, a blowing agent and a highly branched polysaccharide which is derivatized with at least two esters of different length. Further the invention relates to a mix and a process for the production of isocyanate-based polymer. The mix for the production of a foamed isocyanate-based polymer comprises a mixture of the derivatized polysaccharide of the invention and an active hydrogen-containing compound. The process for producing a foamed isocyanate-based polymer comprises the steps of: contacting an isocyanate, an active hydrogen-containing compound, the derivatized highly branched polysaccharide of the invention and a blowing agent to form a reaction mixture and expanding the reaction mixture to produce the foamed isocyanate-based polymer.

Abstract: A printing ink, preferably ink-jet ink, containing pearlescent pigments and at least one of at least one solvent, at least one radiation-curable component and at least one binder, wherein the pearlescent pigments comprise a substantially transparent platelet-shaped substrate having a density ?S and at least one optically active coating having a density ?M, and the pearlescent pigments have a d90 value for a cumulative frequency distribution of a volume-averaged size distribution function with a range from 3.5 to 15 ?m. The invention further relates to a process for producing the printing ink.

Abstract: Provided is a radical-polymerizable resin capable of giving a cured material which is satisfactorily flexible, can relax stress upon usage as an adhesive, and does not cause disadvantages such as separation at the adhesive interface or breakage of an adherend, which stress occurs between the adhesive and the adherend upon heating or cooling and is caused by difference in coefficient of thermal expansion between them. The radical-polymerizable resin is obtained through cationic polymerization of a compound represented by any of following Formulae (1a) and (1b) and a compound represented by any of following Formulae (2a), (2b), (2c), (2d), (2e), and (2f). The radical-polymerizable resin is liquid at 0 ° C. and has a weight-average molecular weight of 500 or more. Symbols in the formulae are as defined in the description.

Abstract: Dental restorative composites having self-healing capabilities to repair discontinuities in the composite are provided. Dental restorative composites according to the present invention include a microsphere that encapsulates a monomer. When a fracture occurs, the microsphere is ruptured and the monomer fills the fracture. Depending on the monomer present in the microsphere, it is polymerized by a polymerization initiator or by an olefin metathesis catalyst present in the dental restorative composite. Self-healing dental restorative composites provide increased resistance to fracturing, and thus remain substantially intact for a longer period of time, preserving the remedial integrity of the dental repair or reconstruction.

Abstract: A radically curable polyurethane composite for dental restorations, including provisional restorations, includes polyurethane dimethacrylate prepolymers that have at least one flexible unit within a polyurethane dimethacrylate backbone, and one or more dimethacrylate monomers. Composite materials made with polyurethane dimethacrylate prepolymers of the invention exhibit superior and optimal properties of flexural strength and deflection-at-break relative to conventional dental resin composites. Composite materials of the invention also provide improved melt-resistance in response to the heat of grinding or finishing, thereby improving the fit of restorations made from the composite and preserving the finishing instruments. Methods of treating a tooth using the radically curable polyurethane composite and methods of making the polyurethane dimethacrylate prepolymers with flexible units is also provided. A kit including the radically curable polyurethane composite is also described.

Abstract: Denture adhesive compositions having good hold and improved taste containing a salt of a copolymer of alkyl vinyl ether-maleic acid or anhydride. Compositions containing from about 25% to about 45%, by weight of the composition, of a salt of a copolymer of alkyl vinyl ether-maleic acid or anhydride containing a cationic salt function containing: i) from about 60% to about 72% cations selected from calcium, strontium, magnesium, or combinations thereof; ii) from 0% to about 10% sodium cations; iii) less than 1% zinc cations; and iv) from about 25% to about 40% of a free acid component; and further containing from about 15% to about 25%, by weight of the composition of a carboxymethyl cellulose having a molecular weight of from about 200,000 to about 1,000,000 daltons; and a carrier. Methods of improving the adhesion of dentures to the oral cavity by applying such compositions to dentures, the oral cavity, or both, and thereafter securing the denture to the ridge or palate of the oral cavity.

Abstract: The present invention relates to a film forming composition comprising a resin and modified nanoparticles comprising nanoparticles and adsorbed thereon a segmented copolymer, preferably a segmented blockcopolymer, comprising an adsorbing segment and a hydrophobic surface active segment, wherein the adsorbing segment has one or more functional groups that adsorb on the nanoparticles and wherein the hydrophobic segment is more hydrophobic than the resin providing surface migration of the nanoparticles. The invention also relates to novel modified particles and the use of the specified segmented copolymer of specified modified particles in a film forming composition for imparting thereto improved surface properties such as scratch resistance.

Abstract: A process for producing a pigment-containing curable resin solution composition which comprises a pigment and a modified polysiloxane is disclosed. The process comprises the steps of: (a) preparing a pigment-dispersed liquid, wherein a pigment is dispersed in an organic solvent in the presence of a first modified polysiloxane; and (b) mixing the pigment-dispersed liquid with a resin solution which comprises at least a second modified polysiloxane. This process provides a pigment-containing curable resin solution composition with excellent dispersion stability of pigment.

Abstract: A method for extrusion of polymer products is provided. The method includes preparing a base mixture in a turbomixer the base mixture containing polymer powders and at least an additive. The method also includes introducing the base mixture into at least an extruder, via a mixer into which an additional quantity of the additive and/or at least a further additive is introduced.

Abstract: A resin material of high strength and high voltage equipment capable of improving the reliability by using the resin material, the resin material being a hardened product including fine particles and resin ingredients, in which the fine particles have hydrophobic groups on the surface and have a particle diameter of 200 nm or less, the resin ingredients have hydrophilic groups on the side chains, and the fine particles form a plurality of linear aggregates inside the resin, thereby forming a dendritic structure.

Abstract: The present invention provides a method for manufacturing a cellulose nanofiber, characterized by comprising the step of fibrillating cellulose in a polyester based resin, preferably in a polyester based resin having an ester group concentration of 6.0 mmol/g or more and a cellulose nanofiber produced by the manufacturing method concerned. In addition, the present invention provides a masterbatch composition containing the cellulose nanofibers and the polyester based resin. Furthermore, the present invention provides a resin composition containing the masterbatch composition and a diluent resin and a processed product thereof.

Abstract: Polyolefin dispersions, froths, and foams and articles manufactured therefrom are disclosed. Also disclosed is a method for generating a thermoplastic foam from an aqueous dispersion. The aqueous dispersion may include a thermoplastic resin, water, and a stabilizing agent. The method may include adding at least one frothing surfactant to the aqueous dispersion to form a mixture, adding a flame retardant and/or a phase change material, frothing the mixture to create a froth, and removing at least a portion of the water to produce the foam.

Abstract: The invention is a method of treating, restoring or sealing a surface comprising applying an emulsion comprising a latex polymer, a cationic emulsifier, and optionally a recycling agent to the surface to wet the surface and depositing a surface treatment layer on the surface, wherein the depositing step occurs while the surface is wetted. The invention also includes a surface pretreatment composition comprising water, at least one acrylic latex polymer, an aromatic recycling agent, and at least one cationic emulsifier. Furthermore, the invention includes the surface resulting from the application of the emulsion used in the invention and concentrated emulsions for use with the surface treatment composition.

Abstract: The flame-retardant thermoplastic resin, composition comprised of the following Components (C), (D) and (E) with the thermoplastic resin composition having a thermoplastic polyurethane elastomer of the Component (A) and an ethylene polymer and/or an ethylene copolymer of the Component (B) as the main components; Component (C): a (poly) phosphate compound represented by the following general formula (1). n in the formula (1) represents a number of 1-100; X1 is an ammonia; or a triazine derivative, represented by the following general formula (2); p is a number satisfying a relation of 0<p?n+2; Component (D): a (poly) phosphate compound represented by the following general formula (3). r in the formula (3) represents a number of 1˜100; Y1 is a diamine containing [R1R2N (CH2)mNR3R4], piperazine or a diamine containing a piperazine ring; R1, R2, R3 and R4 are each a hydrogen atom, or a straight chain or branched alkyl group having 1˜5.

Abstract: The invention relates to a flame retardant composition, wherein the following components: a) At least one flame retardant component selected from the group consisting of phosphinic acid salts and nitrogen containing compounds; and b) At least one polymeric dispersing agent selected from the group consisting of styrenemaleic acid anhydride copolymers, long chain carboxylic acid salts and aliphatic polyether substituted by acidic groups; and c) A polymer substrate; are present.

Abstract: The use of a mixture of 5-pyrimidinol derivatives with sterically hindered phenol derivatives for adjusting the reactivity and the gel time of resin mixtures and reactive resin mortars based on radically polymerizable compounds is described. Furthermore, a resin mixture containing the inhibitor combination, a reactive resin mortar containing this resin mixture and two-component mortar systems with the reactive resin mortar according to the invention and a hardener with improved stability in storage and good low-temperature hardening properties are also described. The resin mixture according to the invention is suitable in particular for chemical fastening of construction elements in boreholes in various substrates.

Abstract: The invention relates to a method for producing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts using a vinyl ester of a carboxylic acid. The method is characterized by the following steps: a) reacting a phosphinic acid source (I) with olefins (IV) in the presence of a catalyst A to give an alkylphosphinic acid, the salt or the ester (II) thereof, b) reacting the alkylphosphinic acid so obtained, the salt or the ester (II) thereof with a vinyl ester of a carboxylic acid of formula (V) in the presence of a catalyst B to give a mono-functionalized dialkylphosphinic acid derivative (VI) and c) reacting the mono-functionalized dialkylphosphinic acid derivative (VI) so obtained in the presence of a catalyst C to give a mono-functionalized dialkylphosphinic acid derivative (VII) and d) reacting the mono-functionalized dialkylphosphinic acid derivative (VII); with an oxidant or in the presence of a catalyst D to give a mono-carboxy-functionalized dialkylphosphinic acid derivative (III).

Abstract: The invention relates to a method for producing mono-carboxyfunctionalized dialkylphosphinic acids and esters and salts thereof, characterized in that a) a phosphinic acid source (I) is reacted with olefins (IV) to yield an alkylphosphonic acid, salt or ester (H) thereof in the presence of a catalyst A, b) the thus obtained alkylphosphonic acid, salt or ester (II) thereof is reacted with compounds of formula (V) to yield mono-functionalized dialkylphosphinic acid derivatives (VI) in the presence of a catalyst B, and c) the thus obtained mono-functionalized dialkylphosphinic acid derivatives (VI) are reacted to yield a mono-carboxyfunctionalized diakylphosphinic acid derivative (III) in the presence of a catalyst C, wherein R1, R2, R3, R4, R5, R6, R7 are the same or different and stand independently of each other, among other things, for H, C1-C18 alkyl, C6-C18 aryl, C6-C18 aralkyl, C6-C18 alkylaryl and X and Y are the same or different and stand independently of each for H, C1-C18 alkyl, C6-C18 aryl, C6-C18 a

Abstract: The present invention relates to an aqueous coating material containing polymer (I), colloidal silica (II), and nonionic surfactant (III) with an HLB value of 16 or more. The polymer (I) is obtained by copolymerization of monomer mixture (M) that contains 0.2 to 10% by mass of monomer (a) having two or more radically polymerizable groups. The solid content of the colloidal silica (II) is 0.1 to 20 parts by mass with respect to 100 parts by mass of the polymer (I). The content of the nonionic surfactant (III) is 0.01 to 10 parts by mass with respect to 100 parts by mass of the polymer (I). The present invention also relates to a painted article where the aqueous coating material is applied. Therefore, an aqueous coating material and a painted article capable of expressing stain resistance and weather resistance can be provided by reducing a water contact angle.

Abstract: To provide a fluorinated elastic copolymer composition, and a cross-linked rubber member obtained by crosslinking the fluorinated elastic copolymer composition, which is excellent in hot water resistance and steam resistance under severe conditions. A fluorinated elastic copolymer composition, which comprises a fluorinated elastic copolymer and a compound represented by the following formula (1) wherein the compound represented by the following formula (1) is contained in an amount of from 0.1 to 10 parts by mass per 100 parts by mass of the fluorinated elastic copolymer: (RCOO?)nMn+??(1) (wherein R is a C10-30 organic group, n is an integer of 2 or 3, and M is an alkaline earth metal, Zn, Cd, Co, Sn, Cu, Pb, Ni or Al).

Abstract: This invention provides a natural solvent-based adhesive composition for tires; a mix to prepare adhesive compositions; a preactivation compound for tires; processes to obtain said compositions or mix; or the use of said compounds in bonding tires; and bonding and preactivation processes for tires. The objects of the invention provide industrial solutions that, while introducing a considerable reduction in environmental impact in their preparation and use, provide better health conditions for the professionals who work in the tire bonding industry.

Abstract: A bearing having a surface and a self-lubricating surface coating composition deposited on the surface, wherein the self-lubricating surface coating composition includes a curable acrylate composition having a metallic composition. The metallic composition having a metallic acrylate compound according to Formula I: and about 30 mass % to about 45 mass % PTFE fiber.

Abstract: A polyester resin containing tungsten-titanium carbide particles having a weight ratio (W/Ti) of tungsten (W) to titanium (Ti) ranging between 5:5 and 7:3 is suitable to produce PET preforms possessed excellent infrared-absorbing capability, and the polyester resin as well as preforms and bottles made from the polyester resin are clearer and have good and less yellowish appearances.